An Extension Study in Subjects With Plaque Psoriasis

Trial Profile

An Extension Study in Subjects With Plaque Psoriasis

Phase of Trial: Phase III

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Brodalumab (Primary)
  • Indications Plaque psoriasis; Psoriatic arthritis
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Kyowa Hakko Kirin
  • Most Recent Events

    • 23 Jul 2015 Results published in a Kyowa Hakko Kirin media release.
    • 24 Mar 2015 Efficacy and tolerability at 1-year results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
    • 15 Feb 2015 Status changed from active, no longer recruiting to completed as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top